OCSAW

distress 2/10 · well-funded / low risk

$4.23-74%today-74% from 52w high

Revenue

pre-revenue

Liquidity

$222M

Runway

3.4 yrs

Shares 1y

—

Price & events

-74.2% over 6M

CatalystRating changeDilutionFinancingdashed = today

-74.3%

-13.1%

-74.3%

—

-74.2%

All

Overview

Volume: 310
52 Week Range: $4.23 – $16.43
RVOL: 0.86x

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: — · 3 offerings/1y · 0 PIPEs

2025-12-08EFFECTshelf_effective
2025-12-01424B3offering
2025-11-10F-3shelf_registration
2025-10-31424B5offering
2025-10-31424B5offering
2025-02-14424B5offering
2024-12-09SC 13Gstrategic_stake

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified